Compounds > 2-(5-bromo-2-pyridylazo)-5-(n-n-propyl-n-3-sulfopropylamino)phenol
Page last updated: 2024-09-04

2-(5-bromo-2-pyridylazo)-5-(n-n-propyl-n-3-sulfopropylamino)phenol and Graves Disease

2-(5-bromo-2-pyridylazo)-5-(n-n-propyl-n-3-sulfopropylamino)phenol has been researched along with Graves Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukazawa, H; Hori, H; Ito, S; Mori, K; Nakagawa, Y; Nakazato, N; Sayama, N; Tani, J; Yoshida, K1

Trials

1 trial(s) available for 2-(5-bromo-2-pyridylazo)-5-(n-n-propyl-n-3-sulfopropylamino)phenol and Graves Disease

ArticleYear
Measurement of red blood cell zinc concentration with Zn-test kit: discrimination between hyperthyroid Graves' disease and transient thyrotoxicosis.
    Endocrine journal, 1998, Volume: 45, Issue:6

    Topics: Adult; Aged; Azo Compounds; Diagnosis, Differential; Erythrocytes; Graves Disease; Humans; Indicators and Reagents; Reagent Kits, Diagnostic; Spectrophotometry, Atomic; Thyroid Function Tests; Thyrotoxicosis; Zinc

1998